Side-effect profile of acitretin therapy in psoriasis (Q44123137)

30 November 2017

Side-effect profile of acitretin therapy in psoriasis (English)

1 reference

30 November 2017

1 reference

Gupta AK

1

1 reference

30 November 2017

Goldfarb MT

series ordinal

2

1 reference

30 November 2017

Ellis CN

series ordinal

3

1 reference

30 November 2017

Voorhees JJ

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 June 1989

1 reference

Journal of the American Academy of Dermatology

30 November 2017

1 reference

30 November 2017

20

1 reference

30 November 2017

6

1 reference

30 November 2017

1088-1093

1 reference

Etretinate kinetics during chronic dosing in severe psoriasis.

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970138-9

7 January 2021

[Teratogenic effects of etretinate in humans]

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970138-9

7 January 2021

Teratogenesis and reproductive safety evaluation of the retinoid etretin (Ro 10-1670).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970138-9

7 January 2021

Etretin therapy for severe psoriasis. Evaluation of initial clinical responses

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970138-9

7 January 2021

Treatment of severe psoriasis with etretin (RO 10-1670)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970138-9

7 January 2021

Treatment of psoriasis with etretin: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970138-9

7 January 2021

Etretinate therapy causes increases in lipid levels in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970138-9

7 January 2021

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970138-9

7 January 2021

Effect of dietary fish oil on hyperlipidaemia due to isotretinoin and etretinate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970138-9

7 January 2021

Fish oil consumption reduces hypertriglyceridemia in psoriatic patients receiving etretinate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970138-9

7 January 2021

Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids. Modulation of clinical course of psoriatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970138-9

7 January 2021

Serial liver biopsies in psoriatic patients receiving long-term etretinate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970138-9

7 January 2021

Long-term effects of etretinate on the liver in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970138-9

7 January 2021

10.1016/S0190-9622(89)70138-9

Identifiers

DOI

1 reference

30 November 2017

1 reference